ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Natural APIs (Active Pharmaceutical Ingredients) Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-18Y18493
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Natural APIs Active Pharmaceutical Ingredients Market Research Report 2024
BUY CHAPTERS

Global Natural APIs (Active Pharmaceutical Ingredients) Market Research Report 2024

Code: QYRE-Auto-18Y18493
Report
November 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roquette Freres SA
Evonik Industries AG
Cargill Inc
Novartis
Sanofi SA
Kothari Phytochemicals
Centroflora Group
Arboris
BASF SE
GSK

Natural APIs (Active Pharmaceutical Ingredients) Market Size

The global Natural APIs (Active Pharmaceutical Ingredients) market was valued at US$ 300 million in 2023 and is anticipated to reach US$ 457 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.

Natural APIs (Active Pharmaceutical Ingredients) Market

Natural APIs (Active Pharmaceutical Ingredients) Market

Natural APIs (Active Pharmaceutical Ingredients) refer to active substances derived from natural sources that are used in the formulation of pharmaceuticals. These can be extracted from plants, animals, minerals, or microorganisms and often have therapeutic properties. Natural APIs play a significant role in modern medicine, providing effective treatments derived from nature. Their use reflects a growing interest in integrating traditional remedies with contemporary pharmaceutical practices.
North American market for Natural APIs (Active Pharmaceutical Ingredients) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Natural APIs (Active Pharmaceutical Ingredients) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Natural APIs (Active Pharmaceutical Ingredients) include Roquette Freres SA, Evonik Industries AG, Cargill, Novartis AG, Sanofi SA, Kothari Phytochemicals, Centroflora Group, Arboris, BASF SE, GSK plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natural APIs (Active Pharmaceutical Ingredients), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural APIs (Active Pharmaceutical Ingredients).
The Natural APIs (Active Pharmaceutical Ingredients) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Natural APIs (Active Pharmaceutical Ingredients) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural APIs (Active Pharmaceutical Ingredients) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Natural APIs (Active Pharmaceutical Ingredients) Market Report

Report Metric Details
Report Name Natural APIs (Active Pharmaceutical Ingredients) Market
Accounted market size in 2023 US$ 300 million
Forecasted market size in 2030 US$ 457 million
CAGR 6.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roquette Freres SA, Evonik Industries AG, Cargill, Novartis AG, Sanofi SA, Kothari Phytochemicals, Centroflora Group, Arboris, BASF SE, GSK plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Natural APIs (Active Pharmaceutical Ingredients) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Natural APIs (Active Pharmaceutical Ingredients) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Natural APIs (Active Pharmaceutical Ingredients) Market growing?

Ans: The Natural APIs (Active Pharmaceutical Ingredients) Market witnessing a CAGR of 6.1% during the forecast period 2024-2030.

What is the Natural APIs (Active Pharmaceutical Ingredients) Market size in 2030?

Ans: The Natural APIs (Active Pharmaceutical Ingredients) Market size in 2030 will be US$ 457 million.

Who are the main players in the Natural APIs (Active Pharmaceutical Ingredients) Market report?

Ans: The main players in the Natural APIs (Active Pharmaceutical Ingredients) Market are Roquette Freres SA, Evonik Industries AG, Cargill, Novartis AG, Sanofi SA, Kothari Phytochemicals, Centroflora Group, Arboris, BASF SE, GSK plc

What are the Application segmentation covered in the Natural APIs (Active Pharmaceutical Ingredients) Market report?

Ans: The Applications covered in the Natural APIs (Active Pharmaceutical Ingredients) Market report are Pharmaceuticals, Biology, Health Products, Others

What are the Type segmentation covered in the Natural APIs (Active Pharmaceutical Ingredients) Market report?

Ans: The Types covered in the Natural APIs (Active Pharmaceutical Ingredients) Market report are Alkaloids, Phenolic Acids, Terpenoids, Lignin, Anthocyanin, Flavonoids, Others

Recommended Reports

Natural & Herbal APIs

API Market Segments

Specialty & Biologic APIs

1 Natural APIs (Active Pharmaceutical Ingredients) Market Overview
1.1 Product Definition
1.2 Natural APIs (Active Pharmaceutical Ingredients) by Type
1.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Value Comparison by Type (2024-2030)
1.2.2 Alkaloids
1.2.3 Phenolic Acids
1.2.4 Terpenoids
1.2.5 Lignin
1.2.6 Anthocyanin
1.2.7 Flavonoids
1.2.8 Others
1.3 Natural APIs (Active Pharmaceutical Ingredients) by Application
1.3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Value by Application (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Biology
1.3.4 Health Products
1.3.5 Others
1.4 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size Estimates and Forecasts
1.4.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue 2019-2030
1.4.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales 2019-2030
1.4.3 Global Natural APIs (Active Pharmaceutical Ingredients) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Natural APIs (Active Pharmaceutical Ingredients) Market Competition by Manufacturers
2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Natural APIs (Active Pharmaceutical Ingredients), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Product Type & Application
2.7 Global Key Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Date of Enter into This Industry
2.8 Global Natural APIs (Active Pharmaceutical Ingredients) Market Competitive Situation and Trends
2.8.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Natural APIs (Active Pharmaceutical Ingredients) Players Market Share by Revenue
2.8.3 Global Natural APIs (Active Pharmaceutical Ingredients) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Natural APIs (Active Pharmaceutical Ingredients) Market Scenario by Region
3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2019-2030
3.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2019-2024
3.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2025-2030
3.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2019-2030
3.3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2019-2024
3.3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2025-2030
3.4 North America Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
3.4.1 North America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2030)
3.4.3 North America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
3.5.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2030)
3.5.3 Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Region
3.6.1 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2019-2030)
3.6.3 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
3.7.1 Latin America Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2030)
3.7.3 Latin America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Facts & Figures by Country
3.8.1 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2019-2030)
4.1.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2019-2024)
4.1.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2025-2030)
4.1.3 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2019-2030)
4.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2019-2030)
4.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2019-2024)
4.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2025-2030)
4.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2019-2030)
4.3 Global Natural APIs (Active Pharmaceutical Ingredients) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2019-2030)
5.1.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2019-2024)
5.1.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2025-2030)
5.1.3 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2019-2030)
5.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2019-2030)
5.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2019-2024)
5.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2025-2030)
5.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2019-2030)
5.3 Global Natural APIs (Active Pharmaceutical Ingredients) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roquette Freres SA
6.1.1 Roquette Freres SA Company Information
6.1.2 Roquette Freres SA Description and Business Overview
6.1.3 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.1.5 Roquette Freres SA Recent Developments/Updates
6.2 Evonik Industries AG
6.2.1 Evonik Industries AG Company Information
6.2.2 Evonik Industries AG Description and Business Overview
6.2.3 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.2.5 Evonik Industries AG Recent Developments/Updates
6.3 Cargill
6.3.1 Cargill Company Information
6.3.2 Cargill Description and Business Overview
6.3.3 Cargill Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cargill Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.3.5 Cargill Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Sanofi SA
6.5.1 Sanofi SA Company Information
6.5.2 Sanofi SA Description and Business Overview
6.5.3 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.5.5 Sanofi SA Recent Developments/Updates
6.6 Kothari Phytochemicals
6.6.1 Kothari Phytochemicals Company Information
6.6.2 Kothari Phytochemicals Description and Business Overview
6.6.3 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.6.5 Kothari Phytochemicals Recent Developments/Updates
6.7 Centroflora Group
6.7.1 Centroflora Group Company Information
6.7.2 Centroflora Group Description and Business Overview
6.7.3 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.7.5 Centroflora Group Recent Developments/Updates
6.8 Arboris
6.8.1 Arboris Company Information
6.8.2 Arboris Description and Business Overview
6.8.3 Arboris Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Arboris Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.8.5 Arboris Recent Developments/Updates
6.9 BASF SE
6.9.1 BASF SE Company Information
6.9.2 BASF SE Description and Business Overview
6.9.3 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.9.5 BASF SE Recent Developments/Updates
6.10 GSK plc
6.10.1 GSK plc Company Information
6.10.2 GSK plc Description and Business Overview
6.10.3 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
6.10.5 GSK plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Natural APIs (Active Pharmaceutical Ingredients) Industry Chain Analysis
7.2 Natural APIs (Active Pharmaceutical Ingredients) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Natural APIs (Active Pharmaceutical Ingredients) Production Mode & Process
7.4 Natural APIs (Active Pharmaceutical Ingredients) Sales and Marketing
7.4.1 Natural APIs (Active Pharmaceutical Ingredients) Sales Channels
7.4.2 Natural APIs (Active Pharmaceutical Ingredients) Distributors
7.5 Natural APIs (Active Pharmaceutical Ingredients) Customers
8 Natural APIs (Active Pharmaceutical Ingredients) Market Dynamics
8.1 Natural APIs (Active Pharmaceutical Ingredients) Industry Trends
8.2 Natural APIs (Active Pharmaceutical Ingredients) Market Drivers
8.3 Natural APIs (Active Pharmaceutical Ingredients) Market Challenges
8.4 Natural APIs (Active Pharmaceutical Ingredients) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roquette Freres SA
Evonik Industries AG
Cargill Inc
Novartis
Sanofi SA
Kothari Phytochemicals
Centroflora Group
Arboris
BASF SE
GSK
List of Tables
 Table 1. Global Natural APIs (Active Pharmaceutical Ingredients) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Natural APIs (Active Pharmaceutical Ingredients) Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Natural APIs (Active Pharmaceutical Ingredients) Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Natural APIs (Active Pharmaceutical Ingredients) Average Price (US$/Ton) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Natural APIs (Active Pharmaceutical Ingredients), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Product Type & Application
 Table 12. Global Key Manufacturers of Natural APIs (Active Pharmaceutical Ingredients), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Natural APIs (Active Pharmaceutical Ingredients) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural APIs (Active Pharmaceutical Ingredients) as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Natural APIs (Active Pharmaceutical Ingredients) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2019-2024) & (Tons)
 Table 18. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Region (2019-2024)
 Table 19. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2025-2030) & (Tons)
 Table 20. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Region (2025-2030)
 Table 21. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region (2019-2024)
 Table 23. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region (2025-2030)
 Table 25. North America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2024) & (Tons)
 Table 27. North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2025-2030) & (Tons)
 Table 28. North America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons) by Type (2019-2024)
 Table 51. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons) by Type (2025-2030)
 Table 52. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2019-2024)
 Table 53. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2025-2030)
 Table 54. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2019-2024)
 Table 57. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2025-2030)
 Table 58. Global Natural APIs (Active Pharmaceutical Ingredients) Price (US$/Ton) by Type (2019-2024)
 Table 59. Global Natural APIs (Active Pharmaceutical Ingredients) Price (US$/Ton) by Type (2025-2030)
 Table 60. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons) by Application (2019-2024)
 Table 61. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons) by Application (2025-2030)
 Table 62. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2019-2024)
 Table 63. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2025-2030)
 Table 64. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2019-2024)
 Table 67. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2025-2030)
 Table 68. Global Natural APIs (Active Pharmaceutical Ingredients) Price (US$/Ton) by Application (2019-2024)
 Table 69. Global Natural APIs (Active Pharmaceutical Ingredients) Price (US$/Ton) by Application (2025-2030)
 Table 70. Roquette Freres SA Company Information
 Table 71. Roquette Freres SA Description and Business Overview
 Table 72. Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 73. Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 74. Roquette Freres SA Recent Developments/Updates
 Table 75. Evonik Industries AG Company Information
 Table 76. Evonik Industries AG Description and Business Overview
 Table 77. Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 78. Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 79. Evonik Industries AG Recent Developments/Updates
 Table 80. Cargill Company Information
 Table 81. Cargill Description and Business Overview
 Table 82. Cargill Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 83. Cargill Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 84. Cargill Recent Developments/Updates
 Table 85. Novartis AG Company Information
 Table 86. Novartis AG Description and Business Overview
 Table 87. Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 88. Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 89. Novartis AG Recent Developments/Updates
 Table 90. Sanofi SA Company Information
 Table 91. Sanofi SA Description and Business Overview
 Table 92. Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 93. Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 94. Sanofi SA Recent Developments/Updates
 Table 95. Kothari Phytochemicals Company Information
 Table 96. Kothari Phytochemicals Description and Business Overview
 Table 97. Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 98. Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 99. Kothari Phytochemicals Recent Developments/Updates
 Table 100. Centroflora Group Company Information
 Table 101. Centroflora Group Description and Business Overview
 Table 102. Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 103. Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 104. Centroflora Group Recent Developments/Updates
 Table 105. Arboris Company Information
 Table 106. Arboris Description and Business Overview
 Table 107. Arboris Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 108. Arboris Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 109. Arboris Recent Developments/Updates
 Table 110. BASF SE Company Information
 Table 111. BASF SE Description and Business Overview
 Table 112. BASF SE Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 113. BASF SE Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 114. BASF SE Recent Developments/Updates
 Table 115. GSK plc Company Information
 Table 116. GSK plc Description and Business Overview
 Table 117. GSK plc Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 118. GSK plc Natural APIs (Active Pharmaceutical Ingredients) Product
 Table 119. GSK plc Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Natural APIs (Active Pharmaceutical Ingredients) Distributors List
 Table 123. Natural APIs (Active Pharmaceutical Ingredients) Customers List
 Table 124. Natural APIs (Active Pharmaceutical Ingredients) Market Trends
 Table 125. Natural APIs (Active Pharmaceutical Ingredients) Market Drivers
 Table 126. Natural APIs (Active Pharmaceutical Ingredients) Market Challenges
 Table 127. Natural APIs (Active Pharmaceutical Ingredients) Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Natural APIs (Active Pharmaceutical Ingredients)
 Figure 2. Global Natural APIs (Active Pharmaceutical Ingredients) Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Natural APIs (Active Pharmaceutical Ingredients) Market Share by Type: 2023 & 2030
 Figure 4. Alkaloids Product Picture
 Figure 5. Phenolic Acids Product Picture
 Figure 6. Terpenoids Product Picture
 Figure 7. Lignin Product Picture
 Figure 8. Anthocyanin Product Picture
 Figure 9. Flavonoids Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Natural APIs (Active Pharmaceutical Ingredients) Market Value by Application (2024-2030) & (US$ Million)
 Figure 12. Global Natural APIs (Active Pharmaceutical Ingredients) Market Share by Application: 2023 & 2030
 Figure 13. Pharmaceuticals
 Figure 14. Biology
 Figure 15. Health Products
 Figure 16. Others
 Figure 17. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Natural APIs (Active Pharmaceutical Ingredients) Market Size (2019-2030) & (US$ Million)
 Figure 19. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (2019-2030) & (Tons)
 Figure 20. Global Natural APIs (Active Pharmaceutical Ingredients) Average Price (US$/Ton) & (2019-2030)
 Figure 21. Natural APIs (Active Pharmaceutical Ingredients) Report Years Considered
 Figure 22. Natural APIs (Active Pharmaceutical Ingredients) Sales Share by Manufacturers in 2023
 Figure 23. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Manufacturers in 2023
 Figure 24. Global 5 and 10 Largest Natural APIs (Active Pharmaceutical Ingredients) Players: Market Share by Revenue in Natural APIs (Active Pharmaceutical Ingredients) in 2023
 Figure 25. Natural APIs (Active Pharmaceutical Ingredients) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 26. Global Natural APIs (Active Pharmaceutical Ingredients) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 27. North America Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2019-2030)
 Figure 28. North America Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Country (2019-2030)
 Figure 29. United States Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Canada Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2019-2030)
 Figure 32. Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Country (2019-2030)
 Figure 33. Germany Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. France Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. U.K. Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Italy Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Russia Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Region (2019-2030)
 Figure 39. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region (2019-2030)
 Figure 40. China Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Japan Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. South Korea Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. India Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Australia Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. China Taiwan Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Latin America Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2019-2030)
 Figure 48. Mexico Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Brazil Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Argentina Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Colombia Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2019-2030)
 Figure 53. Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Country (2019-2030)
 Figure 54. Turkey Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. UAE Natural APIs (Active Pharmaceutical Ingredients) Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Global Sales Market Share of Natural APIs (Active Pharmaceutical Ingredients) by Type (2019-2030)
 Figure 58. Global Revenue Market Share of Natural APIs (Active Pharmaceutical Ingredients) by Type (2019-2030)
 Figure 59. Global Natural APIs (Active Pharmaceutical Ingredients) Price (US$/Ton) by Type (2019-2030)
 Figure 60. Global Sales Market Share of Natural APIs (Active Pharmaceutical Ingredients) by Application (2019-2030)
 Figure 61. Global Revenue Market Share of Natural APIs (Active Pharmaceutical Ingredients) by Application (2019-2030)
 Figure 62. Global Natural APIs (Active Pharmaceutical Ingredients) Price (US$/Ton) by Application (2019-2030)
 Figure 63. Natural APIs (Active Pharmaceutical Ingredients) Value Chain
 Figure 64. Natural APIs (Active Pharmaceutical Ingredients) Production Process
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Sex Hormone APIs Market Research Report 2024
Global NSAID API Market Research Report 2024
Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologic Peptide API Market Research Report 2024
Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025
Global Enzymatic Synthesis of Active Pharmaceutical Ingredients APIs Market Research Report 2024
Veterinary Active Pharmaceutical Ingredients API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide APIs Market Insights Forecast to 2030
Global Anti tuberculosis APIs Market Research Report 2025
Global Oncology API Market Research Report 2024
Global Therapeutic Peptide APIs Market Research Report 2024
Global Fermentation derived Antibiotic APIs Market Research Report 2024
Global Nonsteroidal Anti inflammatory APIs Market Research Report 2024
Global Cytotoxic Active Pharmaceutical Ingredients API Market Research Report 2025
Antibiotics Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nystatin API Market Research Report 2025
Global Rapamycin API Market Research Report 2025
Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sterile Dry Powder Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Corticosteroid API Market Research Report 2025

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions